Regulation of Posttranslational Modifications of HMGB1 During Immune Responses

Antioxidants and Redox Signaling

Volumn 24, Issue 12, 2016, Pages 620-634

  Tang, Yiting ^a,b   Zhao, Xin ^a   Antoine, Daniel ^c   Xiao, Xianzhong ^b   Wang, Haichao ^d   Andersson, Ulf ^e   Billiar, Timothy R ^f   Tracey, Kevin J ^g   Lu, Ben ^a,b,g  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^e KAROLINSKA INSTITUTE   (Sweden)

^f UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^g FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; DOUBLE STRANDED RNA; HIGH MOBILITY GROUP B1 PROTEIN; JANUS KINASE; STAT1 PROTEIN; HMGB1 PROTEIN, HUMAN;

ACETYLATION; APOPTOSIS; BIOLOGICAL ACTIVITY; CELLULAR DISTRIBUTION; HUMAN; IMMUNE RESPONSE; INFLAMMATORY DISEASE; LYSOSOME; NECROPTOSIS; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; OXIDATION; OXIDATION REDUCTION STATE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PYROPTOSIS; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; IMMUNOLOGY; METABOLISM;

HMGB1 PROTEIN; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84966355801     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2015.6409     Document Type: Review

References (99)

1. Andersson U and Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Ann Rev Immunes 29: 139-162, 2011.
2. Andrei C, Margiocco P, Poggi A, Lotti LV, Torrisi MR, and Rubartelli A. Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: implications for inflammatory processes. Proc Natl Acad Sci U S A 101: 9745-9750, 2004.
3. This reference has been deleted.
4. Antoine DJ, Harris HE, Andersson U, Tracey KJ, and Bianchi ME. A systematic nomenclature for the redox states of high mobility group box (HMGB) proteins. Mol Med 20: 135-137, 2014.
5. Antoine DJ, Jenkins RE, Dear JW, Williams DP, McGill MR, Sharpe MR, Craig DG, Simpson KJ, Jaeschke H, and Park BK. Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. J Hepatol 56: 1070-1079, 2012.
6. Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P, Yang H, Amigorena S, Ryffel B, Barrat FJ, Saftig P, Levi F, Lidereau R, Nogues C, Mira JP, Chompret A, Joulin V, Clavel-Chapelon F, Bourhis J, André F, Delaloge S, Tursz T, Kroemer G, and Zitvogel L. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 13: 1050-1059, 2007.
7. Austin M and Neihart NK. Antibodies against chromosomal HMG proteins stain the cytoplasm of mammalian cells. Cell 16: 181-189, 1979.
8. Bianchi ME and Manfredi AA. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev 220: 35-46, 2007.
9. Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A, Rubartelli A, Agresti A, and Bianchi ME. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 22: 5551-5560, 2003.
10. Chavan SS, Huerta PT, Robbiati S, Valdes-Ferrer SI, Ochani M, Dancho M, Frankfurt M, Volpe BT, Tracey KJ, and Diamond B. HMGB1 mediates cognitive impairment in sepsis survivors. Mol Med 18: 930-937, 2012.
11. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, and Chan FK. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137: 1112-1123, 2009.
12. Conti E, Uy M, Leighton L, Blobel G, and Kuriyan J. Crystallographic analysis of the recognition of a nuclear localization signal by the nuclear import factor karyopherin. Cell 94: 193-204, 1998.
13. Dey M, Cao C, Dar AC, Tamura T, Ozato K, Sicheri F, and Dever TE. Mechanistic link between PKR dimerization, autophosphorylation, and eIF2alpha substrate recognition. Cell 122: 901-913, 2005.
14. Dhupar R, Klune JR, Evankovich J, Cardinal J, Zhang M, Ross M, Murase N, Geller DA, Billiar TR, and Tsung A. Interferon regulatory factor 1 mediates acetylation and release of high mobility group box 1 from hepatocytes during murine liver ischemia-reperfusion injury. Shock 35: 293-301, 2011.
15. Dumitriu IE, Baruah P, Valentinis B, Voll RE, Herrmann M, Nawroth PP, Arnold B, Bianchi ME, Manfredi AA, Rovere-Querini P. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol 174: 7506-7515, 2005.
16. Dumitriu IE, Bianchi ME, Bacci M, Manfredi AA, Rovere-Querini P. The secretion of HMGB1 is required for the migration of maturing dendritic cells. J Leukoc Biol 81: 84-91, 2007.
17. Entezari M, Weiss DJ, Sitapara R, Whittaker L, Wargo MJ, Li J, Wang H, Yang H, Sharma L, Phan BD, Javdan M, Chavan SS, Miller EJ, Tracey KJ, and Mantell LL. Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas aeruginosa pneumonia in cystic fibrosis. Mol Med 18: 477-485, 2012.
18. Evankovich J, Cho SW, Zhang R, Cardinal J, Dhupar R, Zhang L, Klune JR, Zlotnicki J, Billiar T, and Tsung A. High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity. J Biol Chem 285: 39888-39897, 2010.
19. Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, Punaro M, Baisch J, Guiducci C, Coffman RL, Barrat FJ, Banchereau J, and Pascual V. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 3: 73ra20, 2011.
20. Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME, and Rubartelli A. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 3: 995-1001, 2002.
21. Ge X, Antoine DJ, Lu Y, Arriazu E, Leung TM, Klepper AL, Branch AD, Fiel MI, and Nieto N. High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD). J Biol Chem 289: 22672-22691, 2014.
22. Ha YM, Ham SA, Kim YM, Lee YS, Kim HJ, Seo HG, Lee JH, Park MK, and Chang KC. β-adrenergic receptor-mediated HO-1 induction, via PI3K and p38 MAPK, by isoproterenol in RAW 264.7 cells leads to inhibition of HMGB1 release in LPS-activated RAW 264.7 cells and increases in survival rate of CLP-induced septic mice. Biochem Pharmacol 82: 769-777, 2011.
23. Hagar JA, Powell DA, Aachoui Y, Ernst RK, and Miao EA. Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science 341: 1250-1253, 2013.
24. Hao N, Budnik BA, Gunawardena J, and O'Shea EK. Tunable signal processing through modular control of transcription factor translocation. Science 339: 460-464, 2013.
25. He S, Wang L, Miao L, Wang T, Du F, Zhao L, and Wang X. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 137: 1100-1111, 2009.
26. Herzig D, Fang G, Toliver-Kinsky TE, Guo Y, Bohannon J, and Sherwood ER. STAT1-deficient mice are resistant to cecal ligation and puncture-induced septic shock. Shock 38: 395-402, 2012.
27. Hett EC, Slater LH, Mark KG, Kawate T, Monks BG, Stutz A, Latz E, and Hung DT. Chemical genetics reveals a kinase-independent role for protein kinase R in pyroptosis. Nat Chem Biol 9: 398-405, 2013.
28. Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, Caffrey DR, Latz E, and Fitzgerald KA. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458: 514-518, 2009.
29. Hsu LC, Park JM, Zhang K, Luo JL, Maeda S, Kaufman RJ, Eckmann L, Guiney DG, and Karin M. The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 428: 341-345, 2004.
30. Huang H, Nace GW, McDonald KA, Tai S, Klune JR, Rosborough BR, Ding Q, Loughran P, Zhu X, Beer-Stolz D, Chang EB, Billiar T, and Tsung A. Hepatocyte specific HMGB1 deletion worsens the injury in liver ischemia/reperfusion: a role for intracellular HMGB1 in cellular protection. Hepatology 59: 1984-1997, 2014.
31. Huang H, Tohme S, Al-Khafaji AB, Tai S, Loughran P, Chen L, Wang S, Kim J, Billiar T, Wang Y, and Tsung A. Damage-associated molecular pattern-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury. Hepatology 62: 600-614, 2015.
32. Irving AT, Wang D, Vasilevski O, Latchoumanin O, Kozer N, Clayton AH, Szczepny A, Morimoto H, Xu D, Williams BR, and Sadler AJ. Regulation of actin dynamics by protein kinase R control of gelsolin enforces basal innate immune defense. Immunity 36: 795-806, 2012.
33. Ito I, Fukazawa J, and Yoshida M. Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils. J Biol Chem 282: 16336-16344, 2007.
34. Javaherian K, Liu JF, and Wang JC. Nonhistone proteins HMG1 and HMG2 change the DNA helical structure. Science 199: 1345-1346, 1978.
35. Jiang W, Bell CW, and Pisetsky DS. The relationship between apoptosis and high-mobility group protein 1 release from murine macrophages stimulated with lipopolysaccharide or polyinosinic-polycytidylic acid. J Immunol 178: 6495-6503, 2007.
36. Jin T, Perry A, Jiang J, Smith P, Curry JA, Unterholzner L, Jiang Z, Horvath G, Rathinam VA, Johnstone RW, Hornung V, Latz E, Bowie AG, Fitzgerald KA, and Xiao TS. Structures of the HIN domain: DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor. Immunity 36: 561-571, 2012.
37. Kang R, Livesey KM, Zeh HJ 3rd, Lotze MT, and Tang D. Metabolic regulation by HMGB1-mediated autophagy and mitophagy. Autophagy 7: 1256-1258, 2011.
38. Kang R, Livesey KM, Zeh HJ, Loze MT, and Tang D. HMGB1: a novel Beclin 1-binding protein active in autophagy. Autophagy 6: 1209-1211, 2010.
39. Kang R, Zhang Q, Hou W, Yan Z, Chen R, Bonaroti J, Bansal P, Billiar TR, Tsung A, Wang Q, Bartlett DL, Whitcomb DC, Chang EB, Zhu X, Wang H, Lu B, Tracey KJ, Cao L, Fan XG, Lotze MT, Zeh HJ 3rd, and Tang D. Intracellular Hmgb1 inhibits inflammatory nucleosome release and limits acute pancreatitis in mice. Gastroenterology 146: 1097-1107, 2014.
40. Kayagaki N, Warming S, Lamkanfi M, VandeWalle L, Louie S, Dong J, Newton K, Qu Y, Liu J, Heldens S, Zhang J, Lee WP, Roose-Girma M, and Dixit VM. Non-canonical inflammasome activation targets caspase-11. Nature 479: 117-121, 2011.
41. Kayagaki N, Wong MT, Stowe IB, Ramani SR, Gonzalez LC, Akashi-Takamura S, Miyake K, Zhang J, Lee WP, Muszyński A, Forsberg LS, Carlson RW, and Dixit VM. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 341: 1246-1249, 2013.
42. Kazama H, Ricci JE, Herndon JM, Hoppe G, Green DR, and Ferguson TA. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 29: 21-32, 2008.
43. Keller M, Rüegg A, Werner S, and Beer HD. Active caspase-1 is a regulator of unconventional protein secretion. Cell 132: 818-831, 2008.
44. Kim JH, Kim SJ, Lee IS, Lee MS, Uematsu S, Akira S, and Oh KI. Bacterial endotoxin induces the release of high mobility group box 1 via the IFN-beta signaling pathway. J Immunol 182: 2458-2466, 2009.
45. Kim SR, Ha YM, Kim YM, Park EJ, Kim JW, Park SW, Kim HJ, Chung HT, and Chang KC. Ascorbic acid reduces HMGB1 secretion in lipopolysaccharide -activated RAW 264.7 cells and improves survival rate in septic mice by activation of Nrf2/HO-1 signals. Biochem Pharmacol 95: 279-289, 2015.
46. Kofoed EM and Vance RE. Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature 477: 592-595, 2011.
47. Lamkanfi M, Sarkar A, VandeWalle L, Vitari AC, Amer AO, Wewers MD, Tracey KJ, Kanneganti TD, and Dixit VM. Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J Immunol 185: 4385-4392, 2010.
48. Lotze MT and Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5: 331-342, 2005.
49. Lourenco MV, Clarke JR, Frozza RL, Bomfim TR, Forny-Germano L, Batista AF, Sathler LB, Brito-Moreira J, Amaral OB, Silva CA, Freitas-Correa L, Espírito-Santo S, Campello-Costa P, Houzel JC, Klein WL, Holscher C, Carvalheira JB, Silva AM, Velloso LA, Munoz DP, Ferreira ST, and De Felice FG. TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's β-amyloid oligomers in mice and monkeys. Cell Metab 18: 831-843, 2013.
50. Lu B, Antoine DJ, Kwan K, Lundbäck P, Wähämaa H, Schierbeck H, Robinson M, Van Zoelen MA, Yang H, Li J, Harris EH, Chavan SS, Wang H, Andersson U, and Tracey KJ. JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation. Proc Natl Acad Sci U S A 111: 3068-3073, 2014.
51. Lu B, Wang H, Andersson U, and Tracey KJ. Regulation of HMGB1 release by inflammasomes. Protein Cell 4: 163-167, 2013.
52. Maugeri N, Campana L, Gavina M, Covino C, De Metrio M, Panciroli C, Maiuri L, Maseri A, D'Angelo A, Bianchi ME, Rovere-Querini P, and Manfredi AA. Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. J Thromb Haemost 12: 2074-2088, 2014.
53. Maugeri N, Franchini S, Campana L, Baldini M, Ramirez GA, Sabbadini MG, Rovere-Querini P, and Manfredi AA. Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis. Autoimmunity 45: 584-587, 2012.
54. Maugeri N, Rovere-Querini P, Baldini M, Baldissera E, Sabbadini MG, Bianchi ME, and Manfredi AA. Oxidative stress elicits platelet/leukocyte inflammatory interactions via HMGB1: a candidate for microvessel injury in systemic sclerosis. Antioxid Redox Signal 20: 1060-1074, 2014.
55. McAllister CS and Samuel CE. The RNA-activated protein kinase enhances the induction of interferon-beta and apoptosis mediated by cytoplasmic RNA sensors. J BiolChem 284: 1644-1651, 2009.
56. Messmer D, Yang H, Telusma G, Knoll F, Li J, Messmer B, Tracey KJ, and Chiorazzi N. High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J Immunol 173: 307-313, 2014.
57. Miao EA, Leaf IA, Treuting PM, Mao DP, Dors M, Sarkar A, Warren SE, Wewers MD, and Aderem A. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol 11: 1136-1142, 2010.
58. Munir M and Berg M. The multiple faces of protein kinase R in antiviral defense. Virulence 4: 85-89, 2013.
59. Murphy JM, Czabotar PE, Hildebrand JM, Lucet IS, Zhang JG, Alvarez-Diaz S, Lewis R, Lalaoui N, Metcalf D, Webb AI, Young SN, Varghese LN, Tannahill GM, Hatchell EC, Majewski IJ, Okamoto T, Dobson RC, Hilton DJ, Babon JJ, Nicola NA, Strasser A, Silke J, and Alexander WS. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 39: 443-453, 2013.
60. Nakamura T, Furuhashi M, Li P, Cao H, Tuncman G, Sonenberg N, Gorgun CZ, and Hotamisligil GS. Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell 140: 338-348, 2010.
61. Nyström S, Antoine DJ, Lundbäck P, Lock JG, Nita AF, Högstrand K, Grandien A, Erlandsson-Harris H, Andersson U, and Applequist SE. TLR activation regulates damage-associated molecular pattern isoforms released during pyroptosis. EMBO J 32: 86-99, 2013.
62. Ohmori Y and Hamilton TA. Requirement for STAT1 in LPS-induced gene expression in macrophages. J Leukoc Biol 69: 598-604, 2001.
63. O'Shea JJ and Plenge R. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 36: 542-550, 2012.
64. Palumbo R, De Marchis F, Pusterla T, Conti A, Alessio M, and Bianchi ME. Src family kinases are necessary for cell migration induced by extracellular HMGB1. J Leukoc Biol 86: 617-623, 2009.
65. Pan PH, Cardinal J, Li ML, Hu CP, and Tsung A. Interferon regulatory factor-1 mediates the release of high mobility group box-1 in endotoxemia in mice. Chin Med J 126: 918-924, 2013.
66. Patel VS, Sitapara RA, Gore A, Phan B, Sharma L, Sampat V, Li JH, Yang H, Chavan SS, Wang H, Tracey KJ, and Mantell LL. High mobility group box-1 mediates hyperoxia-induced impairment of pseudomonas aeruginosa clearance and inflammatory lung injury in mice. Am J Respir Cell Mol Biol 48: 280-287, 2013.
67. Pisetsky DS, Gauley J, and Ullal AJ. HMGB1 and microparticles as mediators of the immune response to cell death. Antioxid Redox Signal 15: 2209-2219, 2011.
68. Pisetsky DS. The expression of HMGB1 on microparticles released during cell activation and cell death in vitro and in vivo. Mol Med 20: 158-163, 2014.
69. Qin S, Wang H, Yuan R, Li H, Ochani M, Ochani K, Rosas-Ballina M, Czura CJ, Huston JM, Miller E, Lin X, Sherry B, Kumar A, Larosa G, Newman W, Tracey KJ, and Yang H. Role of HMGB1 in apoptosis-mediated sepsis lethality. J Exp Med 203: 1637-1642, 2006.
70. Rendon-Mitchell B, Ochani M, Li J, Han J, Wang H, Yang H, Susarla S, Czura C, Mitchell RA, Chen G, Sama AE, Tracey KJ, and Wang H. IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J Immunol 170: 3890-3897, 2003.
71. Rouhiainen A, Imai S, Rauvala H, and Parkkinen J. Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation. Thromb Haemost 84: 1087-1094, 2000.
72. Sakaguchi S, Negishi H, Asagiri M, Nakajima C, Mizutani T, Takaoka A, Honda K, and Taniguchi T. Essential role of IRF-3 in lipopolysaccharide-induced interferon-beta gene expression and endotoxin shock. Biochem Biophys Res Commun 306: 860-866, 2003.
73. Scaffidi P, Misteli T, and Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195, 2002.
74. Souza AC, Yuen PS, and Star RA. Microparticles: markers and mediators of sepsis-induced microvascular dysfunction, immunosuppression, and AKI. Kidney Int 87: 1100-1108, 2015.
75. Strowig T, Henao-Mejia J, Elinav E, and Flavell R. Inflammasomes in health and disease. Nature 481: 278-286, 2012.
76. Tadie JM, Bae HB, Jiang S, Park DW, Bell CP, Yang H, Pittet JF, Tracey K, Thannickal VJ, Abraham E, and Zmijewski JW. HMGB1 promotes neutrophil extracellular trap formation through interactions with Toll-like receptor 4. Am J Physiol Lung Cell Mol Physiol 304: L342-L349, 2013.
77. Tang D, Kang R, Livesey KM, Cheh CW, Farkas A, Loughran P, Hoppe G, Bianchi ME, Tracey KJ, Zeh HJ 3rd, and Lotze MT. Endogenous HMGB1 regulates autophagy. J Cell Biol 190: 881-892, 2010.
78. Tang D, Kang R, Livesey KM, Kroemer G, Billiar TR, Van Houten B, Zeh HJ 3rd, and Lotze MT. High-mobility group box 1 is essential for mitochondrial quality control. Cell Metab 13: 701-711, 2011.
79. Tang D, Kang R, Xiao W, Jiang L, Liu M, Shi Y, Wang K, Wang H, and Xiao X. Nuclear heat shock protein 72 as a negative regulator of oxidative stress (hydrogen peroxide)-induced HMGB1 cytoplasmic translocation and release. J Immunol 178: 7376-7384, 2007.
80. Thapa RJ, Nogusa S, Chen P, Maki JL, Lerro A, Andrake M, Rall GF, Degterev A, and Balachandran S. Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases. Proc Natl Acad Sci U S A 110: E3109-E318, 2013.
81. Tsung A, Klune JR, Zhang X, Jeyabalan G, Cao Z, Peng X, Stolz DB, Geller DA, Rosengart MR, and Billiar TR. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med 204: 2913-2923, 2007.
82. Urbonaviciute V, Fürnrohr BG, Meister S, Munoz L, Heyder P, De Marchis F, Bianchi ME, Kirschning C, Wagner H, Manfredi AA, Kalden JR, Schett G, Rovere-Querini P, Herrmann M, and Voll RE. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 205: 3007-3018, 2008.
83. Venereau E, Casalgrandi M, Schiraldi M, Antoine DJ, Cattaneo A, De Marchis F, Liu J, Antonelli A, Preti A, Raeli L, Shams SS, Yang H, Varani L, Andersson U, Tracey KJ, Bachi A, Uguccioni M, and Bianchi ME. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med 209: 1519-1528, 2012.
84. Venereau E, Schiraldi M, Uguccioni M, and Bianchi ME. HMGB1 and leukocyte migration during trauma and sterile inflammation. Mol Immunol 55: 76-82, 2013.
85. Vogel S, Bodenstein R, Chen Q, Feil S, Feil R, Rheinlaender J, Schäffer TE, Bohn E, Frick JS, Borst O, Münzer P, Walker B, Markel J, Csanyi G, Pagano PJ, Loughran P, Jessup ME, Watkins SC, Bullock GC, Sperry JL, Zuckerbraun BS, Billiar TR, Lotze MT, Gawaz M, and Neal MD. Platelet-derived HMGB1 is a critical mediator of thrombosis. J Clin Invest, 125: 4638-4654, 2015.
86. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, and Tracey KJ. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251, 1999.
87. Wang S, Miura M, Jung YK, Zhu H, Li E, and Yuan J. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 92: 501-509, 1998.
88. West AP, Brodsky IE, Rahner C, Woo DK, Erdjument-Bromage H, Tempst P, Walsh MC, Choi Y, Shadel GS, and Ghosh S. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 472: 476-480, 2011.
89. Williams BR. PKR; a sentinel kinase for cellular stress. Oncogene 18: 6112-6120, 1999.
90. Yanai H, Ban T, Wang Z, Choi MK, Kawamura T, Negishi H, Nakasato M, Lu Y, Hangai S, Koshiba R, Savitsky D, Ronfani L, Akira S, Bianchi ME, Honda K, Tamura T, Kodama T, and Taniguchi T. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462: 99-103, 2009.
91. Yang H, Antoine DJ, Andersson U, and Tracey KJ. The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J Leukoc Biol 93: 865-873, 2013.
92. Yang H, Hreggvidsdottir HS, Palmblad K, Wang H, Ochani M, Li J, Lu B, Chavan S, Rosas-Ballina M, Al-Abed Y, Akira S, Bierhaus A, Erlandsson-Harris H, Andersson U, and Tracey KJ. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci U S A 107: 11942-11947, 2010.
93. Yang X, Wang H, Zhang M, Liu J, Lv B, and Chen F. HMGB1: a novel protein that induced platelets active and aggregation via Toll-like receptor-4, NF-κB and cGMP dependent mechanisms. Diagn Pathol 10: 134, 2015.
94. Ye C, Choi JG, Abraham S, Wu H, Diaz D, Terreros D, Shankar P, and Manjunath N. Human macrophage and dendritic cell-specific silencing of high-mobility group protein B1 ameliorates sepsis in a humanized mouse model. Proc Natl Acad Sci U S A 109: 21052-21057, 2012.
95. Youn JH, Oh YJ, Kim ES, Choi JE, and Shin JS. High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes. J Immunol 180: 5067-5074, 2008.
96. Youn JH and Shin JS. Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J Immunol 177: 7889-7897, 2006.
97. Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, Lin SC, Dong MQ, and Han J. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325: 332-336, 2009.
98. Zhang X, Wheeler D, Tang Y, Guo L, Shapiro RA, Ribar TJ, Means AR, Billiar TR, Angus DC, and Rosengart MR. Calcium/calmodulin-dependent protein kinase (CaMK) IV mediates nucleocytoplasmic shuttling and release of HMGB1 during lipopolysaccharide stimulation of macrophages. J Immunol 181: 5015-5023, 2008.
99. Zhao Y, Yang J, Shi J, Gong YN, Lu Q, Xu H, Liu L, and Shao F. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477: 596-600, 2011.